NF Trinity Capital’s Bristol-Myers Squibb BMY Stock Holding History

NF Trinity Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$6.54M	Buy	137,000 +44,000	+47%	+$2.19M	1.04%	25
2018 Q4	$4.83M	Hold	93,000	–	–	0.79%	30
2018 Q3	$5.77M	Hold	93,000	–	–	0.76%	35
2018 Q2	$5.15M	Hold	93,000	–	–	0.7%	35
2018 Q1	$5.88M	Sell	93,000 -93,000	-50%	-$5.98M	0.81%	32
2017 Q4	$11.4M	Hold	186,000	–	–	1.48%	15
2017 Q3	$11.9M	Hold	186,000	–	–	1.69%	15
2017 Q2	$10.4M	Hold	186,000	–	–	1.47%	16
2017 Q1	$10.1M	Hold	186,000	–	–	1.37%	17
2016 Q4	$10.9M	Sell	186,000 -100,000	-35%	-$5.47M	1.53%	17
2016 Q3	$15.4M	Hold	286,000	–	–	1.72%	16
2016 Q2	$21M	Sell	286,000 -100,000	-26%	-$7.07M	2.3%	15
2016 Q1	$24.7M	Buy	386,000 +64,000	+20%	+$4.04M	2.99%	10
2015 Q4	$22.1M	Buy	+322,000	New	+$21.3M	2.52%	10

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NF Trinity Capital's BMY Position: Q1 2019 in Review

NF Trinity Capital increased its Bristol-Myers Squibb (BMY) stake by 47% in Q1 2019, buying an estimated $2.19M and bringing the position to 137,000 shares worth $6.54M. The position accounts for 1.04% of the portfolio, ranked #25.

NF Trinity Capital first reported a position in BMY in Q4 2015 and has held it in 14 quarters since. The position peaked at $24.7M in Q1 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

NF Trinity Capital held 137,000 shares of Bristol-Myers Squibb worth $6.54M as of Q1 2019.
NF Trinity Capital bought 44,000 Bristol-Myers Squibb shares in Q1 2019, an estimated $2.19M.
Bristol-Myers Squibb made up 1.04% of NF Trinity Capital's portfolio in Q1 2019, its #25 holding.
NF Trinity Capital first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 14 quarters since.
NF Trinity Capital's Bristol-Myers Squibb position peaked at $24.7M in Q1 2016.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on NF Trinity Capital's 13F filing for Q1 2019, filed 10 May 2019.